GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,445 Cr | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,445 Cr |
| Mar2025 | ₹-828 Cr |
| Mar2024 | ₹-265 Cr |
| Mar2023 | ₹625 Cr |
| Mar2022 | ₹1,109 Cr |
How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,445 Cr | Positive | |
| Mar2025 | ₹-828 Cr | Negative | |
| Mar2024 | ₹-265 Cr | Negative | |
| Mar2023 | ₹625 Cr | -43.59 | |
| Mar2022 | ₹1,109 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹66,034.8 Cr | 1.9% | 2.3% | 11.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.9% |
2.3% |
11.2% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses